Pharmacist Portal Dispense an ePrescription
There might be light at the end of the tunnel for Orexigen Therapeutics yet with their weight loss drug, Contrave...
It is still a tense time for pharmaceutical companies who are eager to produce an alternative weight loss treatment to Xenical but Arena Pharmaceuticals Inc...
In February this year Orexigen was asked by the FDA (Food and Drug Administration) to carry out a sizable trial to evaluate the potential cardiovascular risks involved with taking its weight loss drug candidate, Contrave...
In the latest Qnexa news, some exciting results have been published in the Journal of the American Medical Association which Vivus, Qnexa’s creators, hope will win them the approval of the FDA (Food and Drug Administration)...
Vivus will be resubmitting an application to the FDA for the approval of its weight loss drug, Qnexa in the fourth quarter of this year...